===================== Product Identification =====================
MSDS NAME:WT-61, 0049
NIIN:00N092059
Status Code:A
MSDS Number: CJLVJ
=== Responsible Party ===
Company:CERTIFIED LABS DIV OF NCH CORP
Box:152170
City:IRVING
State:TX
ZIP:75015
Country:US
Info Phone Num:972-438-1381
Emergency Phone Num:972-438-1381
Preparer's Name:B. SANFORD
CAGE:53417
=== Contractor Identification ===
Company:CERTIFIED LABS DIV OF NCH CORP
Box:152170
City:IRVING
State:TX
ZIP:75015
Country:US
Phone:214-438-1381972-438-1381
CAGE:53417
============= Composition/Information on Ingredients =============
Name:SODIUM SULFITE. LD50:(ORAL,RAT) >5000 MG/KG.
CAS:7757-83-7
RTECS #:WE2150000
Name:SODIUM LIGNOSULFONATE
CAS:8061-51-6
RTECS #:OI6174000
===================== Hazards Identification =====================
LD50 LC50 Mixture:SEE INGREDIENTS AND TOX INFO
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: EYES: CAUSES SEVERE IRRITATION,
WITH REDNESS AND TEARING. SKIN: CAUSES SEVERE IRRITATION, WHICH MAY
BE SEEN AS REDNESS AND ITCHING. INGESTION: MAY CAUSE NAUSEA,
VOMITING, ABDOMINAL PAIN, GASTRI C IRRITATION, CENTRAL NERVOUS
SYSTEM EFFECTS, DIARRHEA, ACUTE ASTHMA ATTACKS AND LOSS OF
CONSCIOUSNESS. INHALATION: INHALATION OF MIST MAY CAUSE IRRITATION,
BRONCHOSPASM, PNEUMONITIS AND ACUTE ASTHMA ATTACKS. CHRONIC:
REPEATED OR PROLONGED EXPOSURE MAY LEAD TO DERMATITIS. ASTHMATIC
INDIVIDUALS MAY BE HYPERSENSITIVE TO THE SODIUM SULFITE CONTAINED
IN THIS PRODUCT. ALTHOUGH THERE IS NO PRIMARY ROUTE OF ENTRY INTO
THE (EFTS OF OVEREXP)
Explanation of Carcinogenicity:PRODUCT CONTAINS NO CHEMICALS LISTED AS
CARCINOGEN OR POTENTIAL CARCINOGEN BY IARC, NTP, OSHA, ACGIH OR
OTHER.
Effects of Overexposure:HLTH HAZ: BODY, THE PRIMARY ROUTE OF EXPOSURE
IS SKIN AND EYE CONTACT. TARGET ORGANS: LUNGS. NOTE: LEAD AND
MERCURY APPEAR ON THE NAVY LIST OF OCCUPATIONAL CHEMICAL
REPRODUCTIVE HAZARDS. SEEK CONSULTA TION FROM APPROPRIATE HEALTH
PROFESSIONALS CONCERNING LATEST HAZARD LIST INFORMATION & SAFE
HANDLING & EXPOSURE INFORMATION .
Medical Cond Aggravated by Exposure:BREATHING OF MIST MAY AGGRAVATE
ACUTE OR CHRONIC ASTHMA OR OTHER CHRONIC PULMONARY DISEASES.
======================= First Aid Measures =======================
First Aid:INHAL:REMOVE FROM AREA TO FRESH AIR. SEEK MED ATTN IF RESP
IRRIT DEVELS/IF BRTHG BECOMES DFCLT. EYES:IMMED RINSE W/WATER.
REMOVE ANY CONT LENSES & CONTINUE FLUSHING FOR AT LST 15 MINS. HOLD
LIDS APART TO ENSURE RINSING OF ENTIRE SURF OF EYES & LIDS
W/WATER. GET IMMED MED ATTN. SKIN:WASH AFFECTED AREAS W/LG AMTS OF
SOAP & WATER FOR 15 MINS. REMOVE CONTAM CLTHG & SHOES. GET IMMED
MED ATTN. WASH CLTH G & CLEAN SHOES BEFORE REUSE. INGEST:GIVE 3-4
GLASSES OF WATER. INDUCE VOMIT BY PLACING FINGER/BLUNT OBJECT ON
BACK OF VICTIM'S TONGUE. GIVE FLUIDS UNTIL VOMITUS IS CLEAR. SEEK
MED ATTN IF DISCOMFORT OCCURS. NOTES TO MD:IF PATIENT (SUPDAT)
===================== Fire Fighting Measures =====================
Flash Point:NON-FLAMMABLE
Extinguishing Media:FOAM, "ALCOHOL" FOAM, CO*2, DRY CHEMICAL, WATER
SPRAY AND OTHER EXTINGUISHING MEDIA.
Fire Fighting Procedures:USE NIOSH APPROVED SCBA AND FULL PROTECTIVE
EQUIPMENT . EXTINGUISHING MEDIA SHOULD BE CHOSEN BASED ON THE
NATURE OF THE SURROUNDING FIRE. COOL FIRE EXPOSED CONTAINERS WITH
WATER SPRAY.
Unusual Fire/Explosion Hazard:SPILLED MATERIAL MAY BE SPILLERY. NFPA
HAZARD RATING: HEALTH - 2; FLAMMABILITY - 0; REACTIVITY - 0.
================== Accidental Release Measures ==================
Spill Release Procedures:DIKE AND CONTAIN SPILL. ABSORB WITH AN INERT
MATERIAL AND TRANSFER ALL MATERIAL INTO A PROPERLY LABELED
CONTAINER FOR DISPOSAL. WEAR APPROPRIATE PROTECTIVE CLOTHING. USE
CARE AS SPILLS MAY BE SLIPPERY .
Neutralizing Agent:DILUTE INORGANIC ACIDS SUCH AS HYDROCHLORIC ACID.
ADD CAUTIOUSLY WHILE MIXING.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORAGE TEMPERATURE: MAX:120F;
MIN:35F. STORE INDOORS. ALWAYS STORE MATERIAL IN ITS ORIGINAL
CONTAINER. KEEP CONTAINER TIGHTLY CLOSED WHEN NOT IN USE. KEEP FROM
FREEZING. IF PRODUCT FREEZES, WARM TO S TANDARD ROOM TEMPERATURE
SLOWLY AND STIR THOROUGHLY BEFORE USING.
Other Precautions:KEEP OUT OF REACH OF CHILDREN. READ ENTIRE LABEL
BEFORE USING THIS PRODUCT.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:TYPICAL USE OF THIS PRODUCT DOES NOT REQUIRE THE
USE OF SPECIAL RESPIRATORY PROTECTION. A NIOSH APPROVED RESPIRATOR
IN POORLY VENTILATED AREAS OR WHERE MISTING EXISTS.
Ventilation:GENERAL MECHANICAL VENTILATION IS NORMALLY ADEQUATE. LOCAL
VENTILATION IS RECOMMENDED TO CONTROL EXPOSURE FROM OPERATIONS THAT
CAN GENERATE AEROSOLS & MISTS.
Protective Gloves:NEOPRENE RUBBER OR POLYVINYL ALCOHOL GLOVES.
Eye Protection:ANSI APPROVED CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:ANSI APPROVED EYE WASH & DELUGE SHOWER .
WEAR GENERAL DUTY WORK CLOTHING AND SHOES.
Supplemental Safety and Health
FIRST AID PROC: IS EXHIBITING SIGNS OF AN ACUTE ASTHMA REACTION. THE
ACUTE RESPIRATORY DISTRESS MAY BE TREATED WITH EPINEPHRINE, BUT IT
IS ESSENTIAL THAT ALL ADMINISTERED MEDICATIONS CONTAIN NO SULFIT ES
AS PRESERVATIVES.
================== Physical/Chemical Properties ==================
Boiling Pt:=104.4C, 220.F
Vapor Pres:15 MM HG
Vapor Density:0.6
Spec Gravity:1.175 (H*2O=1)
pH:12.4 @ 100%
Viscosity:NON-VISCOUS
Evaporation Rate & Reference:0.10 (BUTYL ACETATE=1)
Solubility in Water:COMPLETE
Appearance and Odor:DARK BROWN, OPAQUE CLARITY; NO ODOR.
Percent Volatiles by Volume:79
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING AGENTS AND MINERAL ACIDS.
Stability Condition to Avoid:AVOID FREEZING TEMPERATURES.
Hazardous Decomposition Products:FUMES OF SULFUR DIOXIDE AND OXIDES OF
CARBON.
=================== Toxicological Information ===================
Toxicological Information:SODIUM SULFITE: HAZARD - IRRITANT.
LD50:(SKIN,RBT) >2000 MG/KG. LD50:(ORAL,MUS) 820 MG/KG. SKN-RBT -
MILD IRRITATION. EYE-RBT - NON IRRITATING. DOSES OF 4-6 GRAMS/DAY
OR 3.5 MG/KG ACUTELY PRODUCED NAU SEA, VOIMTING, ABDOMINAL PAIN,
GASTRIC IRRITATION AND POSSIBLY GASTRIC HEMORRHAGE. DOSES OF 1
GRAM/DAY DID NOT PRODUCE GASTROINTESTINAL SYMPTOMS. REACTIONS IN
ASTHMATICS OCCUR, AT MUCH LOWER DOSES THA N THOSE PRODUCING TOXIC
REACTIONS. THE MINIMUM DOSE TO PRODUCE CENTRAL NERVOUS SYSTEM
EFFECTS IS 6 MG/KG. SODIUM LIGNOSULFONATE: HAZARD - IRRITANT. NO
TOXICITY DATA AVAILABLE.
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE OF I/A/W ALL FEDERAL, STATE AND LOCAL
REGULATIONS.
=================== MSDS Transport Information ===================
Transport Information:(FOR FUTURE USE): LABELS: N/P. LIMITED QTY: N/P.
UNIT CONTAINER: N/P. DOT SPS CONTAINER: N/P. NET EXPLOSIVE WT: N/P.
AEROSOL PROPELLANT(S): N/P.
===================== Regulatory Information =====================
SARA Title III Information:INGREDIENTS SUBJECT TO REPORTING
REQUIREMENTS OF 313 OF TITLE III OF SARA & 40 CFR PART 372: NONE.
IF UE (USE EXEMPTION) APPEARS UNDER UPPER % LIMIT, END USERS ARE
EXEMPT FROM NOTIFICATION BECAUSE THE PRODUCT IS USED & LABELED FOR
ROUTINE JANITORIAL WORK, OR THE PRODUCT IS USED AND LABELED FOR
FACILITY GROUNDS MAINTENANCE (SUCH AS FERTILIZERS AND HERBICIDES).,
OR THE PRODUCT IS USED AND LABELED FO R MAINTAINING MOTOR VEHICLES.
State Regulatory Information:CALIFORNIA PROPOSITION 65: WARNING: THIS
PRODUCT CONTAINS THE FOLLOWING CHEMICAL(S) KNOWN TO THE STATE OF
CALFORNIA TO CAUSE (1) CANCER OR (2) BIRTH DEFECTS OF OTHER
REPRODUCTIVE HARM: ARSENIC (1), CA DMIUM (1), LEAD (2), MERCURY
(2), CHROMIUM (2) AS TRACE CONTAMINANTS.
======================= Other Information =======================
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|